news & events
portfolio news
02.04.19
Aura Biosciences Completes $40 Million Series D Financing
20.03.19
Pfizer secures exclusive option to acquire gene therapy company vivet therapeutics
27.02.19
Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia
15.01.19
Minoryx Therapeutics extends its activities in Belgium
28.11.18
BioClin Therapeutics Announces Name Change to Rainier Therapeutics
30.10.18
Aura Biosciences Presents Updated Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting
26.10.18
Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
24.10.18
JAMA publishes Phase II recAP data for sepsis-associated Acute Kidney Injury
23.10.18
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
18.10.18
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure
